Tumor regression grade combined with post-therapy lymph node status: A novel independent prognostic factor for patients treated with neoadjuvant therapy followed by surgery in locally advanced gastroesophageal junction and gastric carcinoma.
Hongyan YinQian YaoYi XieDongfeng NiuWenya JiangHuiying CaoXujiao FengYanyan LiYilin LiXiaotian ZhangLin ShenYang ChenPublished in: Cancer medicine (2023)
Our results demonstrate that TRG combined with ypN status is a novel independent predictor of both DFS and OS in resectable, locally advanced GEJ and GC. Neoadjuvant immunotherapy achieved the highest TRG0N0 rate.